Mapp Biopharmaceutical Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mapp Biopharmaceutical's estimated annual revenue is currently $12.1M per year.(i)
  • Mapp Biopharmaceutical's estimated revenue per employee is $155,000

Employee Data

  • Mapp Biopharmaceutical has 78 Employees.(i)
  • Mapp Biopharmaceutical grew their employee count by 3% last year.

Mapp Biopharmaceutical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, Sudan DevelopmentReveal Email/Phone
3
VP Quality Control and Analytical DevelopmentReveal Email/Phone
4
VP, Product DevelopmentReveal Email/Phone
5
Director, BioassayReveal Email/Phone
6
Director Project ManagementReveal Email/Phone
7
Director Quality Assurance (GLP/GCP)Reveal Email/Phone
8
Senior Director Nonclinical DevelopmentReveal Email/Phone
9
Associate Director, Nonclinical DevelopmentReveal Email/Phone
10
Senior Director, Head Nonclinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Mapp Biopharmaceutical?

Mapp Biopharmaceutical Inc is a Biotechnology company located in 6160 Lusk Blvd Ste C105, San Diego, California, United States.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$12.1M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mapp Biopharmaceutical News

2022-04-17 - Ebola Virus Vaccine Market Size And Forecast | Mapp ...

Mapp Biopharmaceutical, Serepata Therapeutics, Tekmira Pharmaceuticals, NewLink Genetics Corp., BioCryst Pharmaceutical Inc.

2022-02-22 - CMC Pharmaceuticals Forms Advisory Board

He co-founded Mapp Biopharmaceutical and ZabBio, and serves as President for both companies. His career focus has been on the development of...

2015-10-15 - Ebola drug ZMapp gets orphan status in Europe

“We are hopeful that the Orphan Medicinal Product designation from the EMA will ultimately result in access to ZMapp for those who need it,” CEO Kevin Whaley said in a statement. Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.6M78-5%N/A
#2
$7.5M7842%N/A
#3
$15M78-26%$43.2M
#4
$19.1M785%N/A
#5
$12.5M7810%N/A